Loading of propranolol hydrochloride on mcf and sustained release

被引:0
|
作者
Li X.-D. [1 ]
Zhai Q.-Z. [2 ]
机构
[1] Department of Basic Science, Jilin Jianzhu University, 5088 Xincheng Street, Changchun
[2] Research Center for Nanotechnology, Changchun University of Science and Technology, 7186 Weixing Road, Changchun
关键词
Nanometer mesoporous MCF; Propranolol hydrochloride; Simulated body fluid; Simulated gastric juice; Simulated intestinal fluid; Sustained release;
D O I
10.2174/1876402912999200608141217
中图分类号
学科分类号
摘要
Aims: Adsorption conditions of propranolol hydrochloride onto MCF are optimized. Properties of this adsorption system are studied. The sustained release properties of propranolol hydrochloride in the loading system are also researched. Background: In today's society, demand for drugs is getting higher and higher. With the development of nanotechnology, it is easier to immobilize drugs on nanomaterials, which can easily transport drugs in the human body. It can control drug release, reduce side effects, improve drug efficacy, and develop drug orientation. Objective: The purpose of this study was to load propranolol hydrochloride, a drug for the treatment of heart disease and hypertension on the MCF nano-mesoporous material to prepare a sustainedrelease preparation and investigate the release law of propranolol hydrochloride in simulated human body fluid. Method: Nanometer mesoporous MCF (mesocellular foams) silica material was prepared in acidic medium using triblock copolymer poly(ethylene glycol)-block-poly(propyl glycol)-blockpoly(ethylene glycol) as template and tetraethoxysilane as silica source. Propranolol hydrochloride drug was incorporated into the MCF mesoporous material by the impregnation method to prepare MCF-propranol hydrochloride host-guest composite material. The loading amount of drug was calculated by spectrophotometry and difference subtraction method. Results: The loading amount of drug calculated by spectrophotometry and difference subtraction method was 385.5 mg·g-1 (propranolol hydrochloride/MCF). The adsorption process of propranolol hydrochloride in MCF belongs to the quasi-second-order kinetic process. Adsorption process ΔH0 = 19.11 kJ·mol-1, is an exothermic process, ΔG0 < 0, the adsorption process is a spontaneous process. The effective release time of drug lasted up to 32 h and the maximum cumulative released amount was 99.4 % through the experiment of drug sustained release in the simulated body fluid. In the simulated gastric juice, the release time of drug reached 6 h, and the maximum cumulative released amount was 56.6 %. When drug release time arrived at 10 h in the simulated intestinal fluid, the maximum cumulative released amount was 71.3 %. Conclusion: The influence of the release rate of propranolol hydrochloride molecules from MCF mesopores was demonstrated, since it results in a very slow drug delivery from the nanocomposite system. Thus, it is concluded that the prepared MCF is an efficient drug sustained-released carrier. © 2021 Bentham Science Publishers.
引用
收藏
页码:109 / 118
页数:9
相关论文
共 50 条
  • [1] Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride
    Levis, SR
    Deasy, PB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 253 (1-2) : 145 - 157
  • [2] Preformed microcapsules for loading and sustained release of ciprofloxacin hydrochloride
    Mao, ZW
    Ma, L
    Gao, CY
    Shen, JC
    JOURNAL OF CONTROLLED RELEASE, 2005, 104 (01) : 193 - 202
  • [3] Optimization of propranolol hydrochloride sustained release pellets using a factorial design
    Bodea, A
    Leucuta, SE
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) : 49 - 57
  • [4] FORMULATION OF DISINTEGRATING SUSTAINED-RELEASE TABLETS WITH ENCAPSULATED PROPRANOLOL HYDROCHLORIDE
    CHIAO, CS
    PRICE, JC
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S292 - S292
  • [5] HYDRODYNAMICALLY BALANCED SYSTEMS AS SUSTAINED-RELEASE DOSAGE FORMS FOR PROPRANOLOL HYDROCHLORIDE
    KHATTAR, D
    AHUJA, A
    KHAR, RK
    PHARMAZIE, 1990, 45 (05): : 356 - 358
  • [6] Design and evaluation of sustained-release and buccal adhesive propranolol hydrochloride tablets
    Taylan, B
    Capan, Y
    Guven, O
    Kes, S
    Hincal, AA
    JOURNAL OF CONTROLLED RELEASE, 1996, 38 (01) : 11 - 20
  • [7] Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride
    Gil, Eddy Castellanos
    Colarte, Antonio Iraizoz
    Bataille, Bernard
    Pedraz, Jose Luis
    Rodriguez, Fernand
    Heinamaki, Jyrki
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 317 (01) : 32 - 39
  • [8] HOLLOW FIBERS AS AN ORAL SUSTAINED-RELEASE DELIVERY SYSTEM USING PROPRANOLOL HYDROCHLORIDE
    HUSSAIN, MA
    DILUCCIO, RC
    SHEFTER, E
    HURWITZ, AR
    PHARMACEUTICAL RESEARCH, 1989, 6 (12) : 1052 - 1055
  • [9] Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride
    Feng, Xue-Mei
    Ren, Qi
    Zhang, Wen-Zhi
    Shen, Hui-Feng
    Rong, Zheng-Zing
    Fang, Chao
    Chen, Hong-Zhuan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (07) : 817 - 822
  • [10] SUSTAINED-RELEASE TABLET FORMULATION OF PROPRANOLOL HYDROCHLORIDE BY USING BLENDS OF HYDROXYPROPYLMETHYL CELLULOSE POLYMERS
    PARIKH, NH
    BABAR, A
    PATEL, NK
    PLAKOGIANNIS, FM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S292 - S292